Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Balsa

Showing results (141-150 of 246) with videos related to

Pageof 25
Sort By:
Reumatologia Clinica|January 7, 2014
Practice guidelines for the use of subcutaneous abataceptEmilio Martín Mola, Alejandro Balsa, Víctor Martínez Taboada, et al.
Arthritis Care & Research|November 5, 2011
Effectiveness of a clinical practice intervention in early rheumatoid arthritisMiguel Ángel Descalzo, Jordi Carbonell, Isidoro González-Álvaro, et al.
Pharmacogenetics and Genomics|November 21, 2013
Confirmation of -174G/C interleukin-6 gene promoter polymorphism as a genetic marker predicting antitumor necrosis factor treatment outcomeCristina L Dávila-Fajardo, Ana Márquez, Dora Pascual-Salcedo, et al.
Arthritis Research & Therapy|December 6, 2014
Constitutively altered frequencies of circulating follicullar helper T cell counterparts and their subsets in rheumatoid arthritisIrene Arroyo-Villa, María-Belén Bautista-Caro, Alejandro Balsa, et al.
Reumatologia Clinica|July 29, 2011
[Consensus on the Use of Rituximab in Rheumatoid Arthritis. A document with evidence-based recommendations. Grupo de Expertos en Rituximab. ]Emilio Martín Mola, Blanca Hernández, Miriam García-Arias, et al.
Scientific Reports|June 3, 2021
BAFF predicts immunogenicity in older patients with rheumatoid arthritis treated with TNF inhibitorsBorja Hernández-Breijo, Victoria Navarro-Compán, Chamaida Plasencia-Rodríguez, et al.
Joint Bone Spine|February 21, 2012
A genetic association study of the CLEC12A gene in rheumatoid arthritisLaëtitia Michou, François Cornélis, Jean-Michel Levesque, et al.
Rheumatology International|March 17, 2015
Patterns of use and dosing of tocilizumab in the treatment of patients with rheumatoid arthritis in routine clinical practice: the ACT-LIFE studyAlejandro Balsa, Juan Víctor Tovar Beltrán, Rafael Cáliz Cáliz, et al.
PLOS Digital Health|February 22, 2023
Monitoring chronic inflammatory musculoskeletal diseases mixing virtual and face-to-face assessments-Results of the digireuma studyDiego Benavent, Luis Fernández-Luque, Francisco J Núñez-Benjumea, et al.
Annals of the Rheumatic Diseases|March 12, 2016
Antibodies to infliximab in Remicade-treated rheumatic patients show identical reactivity towards biosimilarsM Begoña Ruiz-Argüello, Ainara Maguregui, Ainhoa Ruiz Del Agua, et al.
Pageof 25

Showing results (141-150 of 246) with videos related to

Sort By:
Pageof 25
Reumatologia Clinica|January 7, 2014
Practice guidelines for the use of subcutaneous abataceptEmilio Martín Mola, Alejandro Balsa, Víctor Martínez Taboada, et al.
Arthritis Care & Research|November 5, 2011
Effectiveness of a clinical practice intervention in early rheumatoid arthritisMiguel Ángel Descalzo, Jordi Carbonell, Isidoro González-Álvaro, et al.
Pharmacogenetics and Genomics|November 21, 2013
Confirmation of -174G/C interleukin-6 gene promoter polymorphism as a genetic marker predicting antitumor necrosis factor treatment outcomeCristina L Dávila-Fajardo, Ana Márquez, Dora Pascual-Salcedo, et al.
Arthritis Research & Therapy|December 6, 2014
Constitutively altered frequencies of circulating follicullar helper T cell counterparts and their subsets in rheumatoid arthritisIrene Arroyo-Villa, María-Belén Bautista-Caro, Alejandro Balsa, et al.
Reumatologia Clinica|July 29, 2011
[Consensus on the Use of Rituximab in Rheumatoid Arthritis. A document with evidence-based recommendations. Grupo de Expertos en Rituximab. ]Emilio Martín Mola, Blanca Hernández, Miriam García-Arias, et al.
Scientific Reports|June 3, 2021
BAFF predicts immunogenicity in older patients with rheumatoid arthritis treated with TNF inhibitorsBorja Hernández-Breijo, Victoria Navarro-Compán, Chamaida Plasencia-Rodríguez, et al.
Joint Bone Spine|February 21, 2012
A genetic association study of the CLEC12A gene in rheumatoid arthritisLaëtitia Michou, François Cornélis, Jean-Michel Levesque, et al.
Rheumatology International|March 17, 2015
Patterns of use and dosing of tocilizumab in the treatment of patients with rheumatoid arthritis in routine clinical practice: the ACT-LIFE studyAlejandro Balsa, Juan Víctor Tovar Beltrán, Rafael Cáliz Cáliz, et al.
PLOS Digital Health|February 22, 2023
Monitoring chronic inflammatory musculoskeletal diseases mixing virtual and face-to-face assessments-Results of the digireuma studyDiego Benavent, Luis Fernández-Luque, Francisco J Núñez-Benjumea, et al.
Annals of the Rheumatic Diseases|March 12, 2016
Antibodies to infliximab in Remicade-treated rheumatic patients show identical reactivity towards biosimilarsM Begoña Ruiz-Argüello, Ainara Maguregui, Ainhoa Ruiz Del Agua, et al.
Pageof 25